AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21722168
Drug: Heparin (0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (0.7 mL, 10 units/mL)
Trial: 21722168
Drug: Saline (0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (0.7 mL)
Trial: 16540702
Drug: Other SGA
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other SGA drugs
Trial: 10736383
Drug: Monosodium glutamate
RxNorm normalized name: Monosodium Glutamate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monosodium glutamate (MSG) at a dose of 2500 mg
Trial: 9363292
Drug: Valproate (individualized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valproate (individualized dosing according to response and side effects)
Trial: 1313100
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg minocycline per day for 8 days
Trial: 1313100
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg minocycline per day for 8 days
Trial: 4008643
Drug: Interferon alpha
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha (IFN) at a dose of 3 X 10(6) U
Trial: 4008643
Drug: Interferon alpha
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha (IFN) at doses of 3 X 10(6), 10(7), and 3 X 10(7) U
Trial: 4008643
Drug: Pre-injection PMC
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein Injection [Arexvy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-injection PMC cultured overnight
Trial: 26525369
Drug: OFIRMEV 1
RxNorm normalized name: Ofirmev 10 MG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OFIRMEV 1 g every 6 hours for 24 hours
Trial: 22130164
Drug: Ipilimumab at
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ipilimumab at 10 mg/kg every 3 weeks for 4 doses
Trial: 22130164
Drug: Budesonide (oral)
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide (oral)
Trial: 28133708
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg on-demand tadalafil (OD-TAD)
Trial: 28133708
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg daily tadalafil (OAD-TAD)
Trial: 21816087
Drug: Presumptive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presumptive treatment for all
Trial: 12610183
Drug: Cyclophosphamide (C;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide (C; 75 mg/m(2) orally days 1 to 14), epirubicin (E; 60 mg/m(2) IV days 1, 8), and fluorouracil (F; 500 mg/m(2) IV days 1, 8) - CEF arm
Trial: 12610183
Drug: Epirubicin (E;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin (E; 120 mg/m(2) IV day 1), Cyclophosphamide (C; 830 mg/m(2) IV day 1), and filgrastim (5 micro g/kg/d subcutaneously days 2 to 13) - EC arm
Trial: 23998433
Drug: Oral paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral paracetamol (1 g) plus intravenous ketorolac (30 mg i.v. once daily)
Trial: 23998433
Drug: Intravenous ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketorolac (30 mg i.v. once daily) alone
Trial: 21558299
Drug: ACT measured
RxNorm normalized name: ACT-101
DrugBank: ACT-101 (DB17000)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT measured at 1 min after heparin injection
Trial: 21558299
Drug: ACT measured
RxNorm normalized name: ACT-101
DrugBank: ACT-101 (DB17000)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT measured at 2 min after heparin injection
Trial: 21558299
Drug: ACT measured
RxNorm normalized name: ACT-101
DrugBank: ACT-101 (DB17000)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT measured at 3 min after heparin injection
Trial: 21558299
Drug: ACT measured
RxNorm normalized name: ACT-101
DrugBank: ACT-101 (DB17000)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT measured at 4 min after heparin injection
Trial: 21558299
Drug: ACT measured
RxNorm normalized name: ACT-101
DrugBank: ACT-101 (DB17000)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT measured at 5 min after heparin injection
Trial: 19746676
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg drospirenone plus 20 microg ethinylestradiol (24/4 regimen)
Trial: 11435053
Drug: 30 ppm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ppm inhaled nitric oxide
Trial: 8037411
Drug: Sulindac and
RxNorm normalized name: Sulindac
DrugBank: Sulindac (DB00605)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulindac and Aspirin
Trial: 30477915
Drug: Control (intracytoplasmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (intracytoplasmic sperm injection)
Trial: 21698991
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health education (OHE) every 3 months
Trial: 9049584
Drug: Oral fluconazole
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral fluconazole 400 mg
Trial: 9049584
Drug: Intravenous fluconazole
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous fluconazole 400 mg
Trial: 8349330
Drug: Fish or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish or fish oil supplements (6 or 12 fish-oil capsules daily, fish meals providing 1.3 g of eicosapentaenoic acid, or a combination of fish oil and fish)
Trial: 2939691
Drug: Zimeldine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zimeldine (100 mg b.i.d.)
Trial: 27356143
Drug: Topical insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical insulin (1 U/cm2 wound area), applied twice daily for 7 days.
Trial: 27356143
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline dressing (control group), applied twice daily for 7 days.
Trial: 19076574
Drug: Nerve block
RxNorm normalized name: Nerve Block Tray 22g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nerve block of the auricular branch of the Vagus (Nerve of Arnold) with 0.2 ml of 0.25% bupivacaine
Trial: 19076574
Drug: Intranasal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal fentanyl 2 mcg.kg(‐1)
Trial: 16115360
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (providing 2.7 g/d EPA and DHA) plus antioxidants (vitamins A, C and E, and Se)
Trial: 11990448
Drug: Methods to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methods to modulate the host response in periodontal therapy
Trial: 7486080
Drug: Procaine hydrochloride
RxNorm normalized name: Procaine Hydrochloride
DrugBank: Procaine (DB00721)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Procaine hydrochloride (1 mM) added to St. Thomas' Hospital cardioplegic solution II (Plegisol)
Trial: 7486080
Drug: Saline added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline added to St. Thomas' Hospital cardioplegic solution II (Plegisol)
Trial: 2119786
Drug: Oral-aural group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-aural group
Trial: 17521302
Drug: Antiplatelet drug
RxNorm normalized name: simethicone
DrugBank: Simethicone (DB09512)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet drug users
Trial: 17521302
Drug: Non-users of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-users of antiplatelet drugs
Trial: 11410112
Drug: High-dose GIK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose GIK
Trial: 9429742
Drug: Letrozole 2.5
RxNorm normalized name: letrozole 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole 2.5 mg orally (p.o.)
Trial: 9429742
Drug: Letrozole 2.5
RxNorm normalized name: letrozole 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole 2.5 mg intravenously (i.v.)
Trial: 9429742
Drug: Letrozole 2.5
RxNorm normalized name: letrozole 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole 2.5 mg orally (p.o.) and intravenously (i.v.)
Trial: 8220938
Drug: Maxepa (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maxepa (10 capsules per day for 12 months)
Trial: 8220938
Drug: Placebo (air-filled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (air-filled capsules, 10 per day for 12 months)
Trial: 3629186
Drug: Intravenous cholecystokinin
RxNorm normalized name: cholecystokinin
DrugBank: Cholecystokinin (DB08862)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cholecystokinin (CCK)
Trial: 3629186
Drug: Oral bile
RxNorm normalized name: bile salts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bile acid load of 500 mg chenodeoxycholic acid (CDA)
Trial: 24473926
Drug: Psychological treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychological treatments for PTSD
Trial: 22942337
Drug: β-blocker (BB)
RxNorm normalized name: capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: β-blocker (BB)
Trial: 16814412
Drug: 17beta-estradiol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17beta-estradiol (1 mg)
Trial: 15591730
Drug: Prescription of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescription of fluoride lozenges
Trial: 12405170
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation at a dose of 2 mg/kg/day
Trial: 12405170
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation at a dose of 2 mg/kg/every other day
Trial: 12405170
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation at a dose of 1 mg/kg/day
Trial: 6994301
Drug: Single-morning daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-morning daily prednisone treatment
Trial: 6994301
Drug: Alternate-day prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alternate-day prednisone treatment
Trial: 28490674
Drug: Liquid oil
RxNorm normalized name: castor oil Oral Liquid Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid oil (22.25 g coconut oil or sunflower oil)
Trial: 28490674
Drug: Oleogel (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oleogel (25 g coconut oleogel or sunflower oleogel)
Trial: 22432725
Drug: Flax seed
RxNorm normalized name: FLAX SEED
DrugBank: Flax seed (DB10708)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flax seed powder (10 g daily for 1 month)
Trial: 17588299
Drug: etoricoxib 120
RxNorm normalized name: etoricoxib 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etoricoxib 120 mg once daily
Trial: 17588299
Drug: indomethacin 50
RxNorm normalized name: indomethacin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: indomethacin 50 mg three times daily
Trial: 11451727
Drug: Bread with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bread with 1.2 mg Zn and 17 microg folic acid (A)
Trial: 11451727
Drug: Bread with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bread with 1.2 mg Zn and 144 microg folic acid (B)
Trial: 11451727
Drug: Bread with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bread with 3.0 mg Zn and 17 microg folic acid (C)
Trial: 11451727
Drug: Bread with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bread with 2.9 mg Zn and 144 microg folic acid (D)
Trial: 7752830
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 mg plus CoQ10 100 mg
Trial: 22574377
Drug: Yimusake 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yimusake 1 tablet (50 mg) per day for 4 weeks
Trial: 22574377
Drug: Trazodone hydrochloride
RxNorm normalized name: Trazodone Hydrochloride
DrugBank: Trazodone (DB00656)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trazodone hydrochloride 1 tablet (50 mg) per day for 4 weeks
Trial: 17686104
Drug: Steroid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid treatment or allergen provocation
Trial: 9013366
Drug: rHu GM‐CSF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHu GM‐CSF (5 micrograms/kg subcutaneously daily for 4 days)
Trial: 9013366
Drug: rHu GM‐CSF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHu GM‐CSF after the first dose
Trial: 9013366
Drug: Zidovudine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine (200 mg orally every 8 hours)
Trial: 23923597
Drug: Routine drug
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine drug treatment (control group)
Trial: 17464552
Drug: Hydration supplementation
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydration supplementation (1500 ml of water + 1500 mg of NaCl/day)
Trial: 7909999
Drug: Topical levocabastine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical levocabastine (eye drops and nasal spray)
Trial: 3299678
Drug: Propranolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (10 mg intravenously twice daily) + Neostigmine (0.5 mg subcutaneously twice daily)
Trial: 3299678
Drug: Neostigmine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine (0.5 mg subcutaneously twice daily)
Trial: 20843456
Drug: Pelvic floor
RxNorm normalized name: Tenscare Kegel Toner Pelvic Floor Trainer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelvic floor exercises (16 sessions, twice a week for 30 minutes)
Trial: 18164521
Drug: Preventive AIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive AIDS vaccine
Trial: 10590282
Drug: Imipenem/cilastatin 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem/cilastatin 1 g iv three-times daily
Trial: 7797060
Drug: Inhaled beta
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beta 2-agonists
Trial: 2194992
Drug: Amitriptyline (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (150 mg/day)
Trial: 2194992
Drug: Amitrypylinoxide (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitrypylinoxide (150 mg/day)
Trial: 29450728
Drug: 20 µg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 µg/day of vitamin D3
Trial: 29572676
Drug: 10 µg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 µg/day of vitamin D3
Trial: 25820474
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) 1.3 g/day
Trial: 25820474
Drug: α-lipoic acid
RxNorm normalized name: α-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α-lipoic acid 0.3 g/day
Trial: 25820474
Drug: Both EPA
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both EPA (1.3 g/day) and α-lipoic acid (0.3 g/day)
Trial: 24059443
Drug: Interactive Metronome
RxNorm normalized name: Menin-mll interaction inhibitor ko 539
DrugBank: Ziftomenib (DB17171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interactive Metronome (IM) therapy
Trial: 16832589
Drug: Medication (MED)
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (MED) - extended release oxybutynin at 5 mg/day for 3 months
Trial: 15516392
Drug: Oxytocin bolus
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin bolus dose
Trial: 31551154
Drug: Cytokine enrichment
RxNorm normalized name: cytosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytokine enrichment of culture medium (granulocyte‐macrophage colony‐stimulating factor, heparin‐binding epidermal growth factor‐like growth factor, and leukemia inhibitory factor)
Trial: 28669793
Drug: 5% methylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% methylene blue mediated photodynamic therapy using Fotosan device for 30s (630nm wavelength and 7.2‐14.4J/cm2 dose) for 4 sessions
Trial: 28669793
Drug: 0.5mg tab
RxNorm normalized name: DIGOXIN 0.5MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5mg tab dexamethasone solution in 5cc water, rinsed 4 times a day for two weeks
Trial: 26134837
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (standard hypertension treatment recommendations)
Trial: 23786760
Drug: Etanercept 2
RxNorm normalized name: etanercept 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 2 × 25 mg s.c./week
Trial: 16835670
Drug: Nurse-centred surveillance
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nurse-centred surveillance and treatment
Trial: 16835670
Drug: Combined endpoint
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined endpoint (LDL-C < 2.5 mmol/L, triglycerides < 2.0 mmol/L, total cholesterol/HDL < 4.0)
Trial: 15074086
Drug: Naoreqing oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naoreqing oral liquid (NRQ)
Trial: 15074086
Drug: Naoreqing oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naoreqing oral liquid (NRQ) plus western medicine (WM)
Trial: 10732177
Drug: Routine conventional
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine conventional therapy
Trial: 8882986
Drug: CT plus
RxNorm normalized name: Protect Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CT plus IFN alpha‐2a (3 MU/m2 twice weekly)
Trial: 2408735
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy with methotrexate, bleomycin, and cisplatin
Trial: 3324523
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g single dose of amoxicillin
Trial: 3324523
Drug: 4-day course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-day course of 3 doses of 750 mg amoxicillin
Trial: 23782128
Drug: Extended-release methylphenidate
RxNorm normalized name: methylphenidate Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release methylphenidate (MPH)
Trial: 18423697
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg dutasteride
Trial: 18423697
Drug: 5alpha-reductase inhibitors
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5alpha-reductase inhibitors (dutasteride and finasteride)
Trial: 9199074
Drug: Enoxaparin 1
RxNorm normalized name: ENOXAPARIN 100MG/ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 1 x 40 mg per day
Trial: 9199074
Drug: Na-heparin 3
RxNorm normalized name: Heparin Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Na-heparin 3 x 5000 IE (increased to 3 x 7500 IE if PTT did not reach 40 seconds)
Trial: 28687281
Drug: Peak NSE
RxNorm normalized name: PEAK FLOW METER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peak NSE >38ng/l
Trial: 28687281
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of peak NSE >38ng/l and generalised oedema on CT
Trial: 23588803
Drug: Recent developments
RxNorm normalized name: petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recent developments (sensory discrimination training, mirror treatment, graded motor imagery, prosthesis training, training in virtual reality)
Trial: 17342992
Drug: Compound Shenhua
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound Shenhua Tablet (SHT)
Trial: 14990014
Drug: Propranolol 10-20
RxNorm normalized name: propranolol 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 10-20 mg orally three times a day for 7 days
Trial: 14990014
Drug: Octreotide 0.05
RxNorm normalized name: octreotide 0.05 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide 0.05 mg subcutaneously two times a day for 3 days
Trial: 14990014
Drug: Octreotide 0.1
RxNorm normalized name: octreotide 0.1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide 0.1 mg subcutaneously two times a day for 3 days
Trial: 11772796
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of midazolam (M group)
Trial: 2649317
Drug: buspirone (24.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: buspirone (24.5 mg daily)
Trial: 2649317
Drug: diazepam (20.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diazepam (20.8 mg daily, range 10 mg to 60 mg)
Trial: 715070
Drug: Vaginal suppositories
RxNorm normalized name: Miconazole Nitrate Vaginal Suppositories
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal suppositories of 15(S)15 methyl prostaglandin F2 alpha methyl ester (50 cases)
Trial: 29045302
Drug: Pregnenolone (add-on
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregnenolone (add-on treatment)
Trial: 17139034
Drug: Adherence therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adherence therapy